Original Research
The goal of the present study was to survey patients with AD and caregivers to establish what they considered to be the most important treatment goals, thereby providing data for the systematic incorporation of these goals into Alzheimer disease clinical trials.
Review
There is some evidence that propranolol may benefit individuals with behavioural and psychological symptoms of dementia (BPSD). This article discusses three case series that assessed the use of propranolol for the management of BPSD. From these studies, it appears that propranolol improves BPSD and is well tolerated. In clinical practice, the routine use of propranolol among people with BPSD cannot be recommended at this time given the limited data. However, propranolol can be trialled among individuals with BPSD when symptoms have not responded adequately to other medications.
Editorial
This editorial reviews the trial data for aducanumab in the treatment of Alzheimer’s disease and the controversies that its approval has generated.
Review
This review assesses the efficacy and tolerability of analgesics in reducing behavioral and psychological symptoms of dementia among older adults from published randomized controlled trials.
